This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Allergic Bronchopulmonary Aspergillosis
and you are
between 12 and 70
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The purpose of this study is to evaluate the efficacy and safety of itraconazole monotherapy in patients with ABPA.

Provided treatments

  • Drug: Glucocorticoids
  • Drug: Itraconazole

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01321827. The sponsor of the trial is Postgraduate Institute of Medical Education and Research and it is looking for 100 volunteers for the current phase.
Official trial title: